The healthcare community is buzzing by retatrutide, a innovative dual GIP and GLP-1 target that’s showing significant results in clinical studies . This compound works by mimicking natural hormones to affect appetite and increase feelings of fullness , ultimately leading substantial fat reduction . While presently under investigation and not broa